Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Study shows hyperthermia improves effectiveness of radiation therapy
June 6th, 2005
BSD Medical Corp. (BSDM) announced that researchers from Duke University Medical Center have authored a report in the Journal of Clinical Oncology, which describes a striking clinical advantage in the use of hyperthermia, or heat therapy, as an adjuvant to radiation therapy for patients with post-mastectomy chest wall recurrence, in comparison to patients who have been treated with radiotherapy alone. According to the study, patients with post-mastectomy chest wall recurrence of breast cancer who were given hyperthermia (HT) treatment (heat therapy) as an adjunct to standard radiation experienced complete response (total disappearance of the tumor) at a rate...
Source: Biotech Business Week (2005-06-06)
|
